Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Salvetti M, Wray S, Nelles G, Belviso N, Kumar A, Koster T, Castro-Borrero W, Vignos M; POP Investigators. Salvetti M, et al. Among authors: koster t. Mult Scler J Exp Transl Clin. 2024 May 23;10(2):20552173241238632. doi: 10.1177/20552173241238632. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38784791 Free PMC article.
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational Program.
Salvetti M, Wray S, Nelles G, Altincatal A, Kumar A, Koster T, Naylor ML; Plegridy Observational Program investigators. Salvetti M, et al. Among authors: koster t. Mult Scler Relat Disord. 2022 Jan;57:103350. doi: 10.1016/j.msard.2021.103350. Epub 2021 Oct 29. Mult Scler Relat Disord. 2022. PMID: 35158459 Free article.
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey.
Tumani H, Coyle PK, Cárcamo C, Cordioli C, López PA, Peterka M, Ramo-Tello C, Zuluaga MI, Koster T, Vignos M. Tumani H, et al. Among authors: koster t. Mult Scler J Exp Transl Clin. 2023 Sep 13;9(3):20552173231198588. doi: 10.1177/20552173231198588. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37720692 Free PMC article.
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.
Cutter G, Rudick RA, de Moor C, Singh CM, Fisher E, Koster T, Lublin FD, Wolinsky JS, McFarland H, Jacobson S, Naylor ML. Cutter G, et al. Among authors: koster t. Mult Scler J Exp Transl Clin. 2023 Apr 27;9(2):20552173231169463. doi: 10.1177/20552173231169463. eCollection 2023 Apr-Jun. Mult Scler J Exp Transl Clin. 2023. PMID: 37139460 Free PMC article.
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study.
Castelnovo G, Gerlach O, Freedman MS, Bergmann A, Sinay V, Castillo-Triviño T, Kong G, Koster T, Williams H, Gafson AR, Killestein J. Castelnovo G, et al. Among authors: koster t. CNS Drugs. 2021 Sep;35(9):1009-1022. doi: 10.1007/s40263-021-00840-x. Epub 2021 Jul 28. CNS Drugs. 2021. PMID: 34322853 Free PMC article. Clinical Trial.
Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.
Hupperts R, Gasperini C, Lycke J, Ziemssen T, Feys P, Xiao S, Acosta C, Koster T, Hobart J. Hupperts R, et al. Among authors: koster t. Ther Adv Neurol Disord. 2022 May 18;15:17562864221090398. doi: 10.1177/17562864221090398. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35601756 Free PMC article.
Highlights from the 11th Bronchitis International Symposium: "Heterogeneity of Lung Disease in a Changing Environment," Groningen, The Netherlands, 2024.
Pouwels SD, Ter Haar EAMD, Heijink IH, Hylkema MN, Koster TD, Kuks PJM, Maassen S, Slebos DJ, Vasse GF, de Vries M, Woldhuis RR, Brandsma CA. Pouwels SD, et al. Among authors: koster td. Respiration. 2024 Sep 30:1-12. doi: 10.1159/000541655. Online ahead of print. Respiration. 2024. PMID: 39348815 Free article.
Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease.
Lemson A, Koster TA, Carpaij N, Magis-Escurra C, Boeree M, Stemkens R, Aarnoutse RE, van Laarhoven A, van Crevel R, van Ingen J, Hoefsloot W. Lemson A, et al. Among authors: koster ta. IJTLD Open. 2024 Jun 1;1(6):279-281. doi: 10.5588/ijtldopen.24.0044. eCollection 2024 Jun. IJTLD Open. 2024. PMID: 39021452 Free PMC article. No abstract available.
156 results